Why Trade Finance Matters in Medical Device Export

Medical device exports face three compounding financial risks that trade finance is designed to solve: buyer credit risk (will the distributor pay?), country risk (will the country allow funds to be transferred?), and currency risk (will exchange rate movement erode the margin?). Turkish medical device exporters selling into emerging markets face all three simultaneously.

Choosing the wrong payment structure is the most common financial mistake Turkish manufacturers make in their first years of export. Shipping on open account terms to an unknown distributor in a high-risk country has destroyed more export departments than poor product quality or regulatory failure combined.

1. Letter of Credit (L/C) — The Gold Standard for Emerging Markets

A Letter of Credit is an irrevocable payment undertaking issued by the buyer's bank, guaranteeing payment to the Turkish exporter upon presentation of compliant shipping documents. It is the safest payment instrument for first-time transactions with new distributors in markets with elevated country or buyer risk.

Recommended for: First transactions with new distributors in Africa, Middle East, Central Asia, and Latin America. Essential for orders above USD 50,000 in markets rated CCC or below by OECD.

2. Documentary Collection (D/P and D/A) — The Middle Ground

Documentary Collection involves the Turkish exporter's bank forwarding shipping documents to the buyer's bank, releasing them only when the buyer pays (D/P — Documents against Payment) or accepts a draft (D/A — Documents against Acceptance). Less secure than an L/C but cheaper and faster.

D/P (Sight): The buyer must pay to receive shipping documents. Goods cannot be cleared through customs without the Bill of Lading. Risk: if the buyer refuses payment, goods are stranded at the port — you must arrange return shipment or find a local buyer.

D/A (Term): The buyer accepts a usance draft (30, 60, or 90 days) to receive documents. They have committed to pay but have not yet paid. Risk: buyer insolvency during the credit period. Use only with established, creditworthy distributors.

Recommended for: Repeat transactions with known distributors in medium-risk markets. OECD country risk Category 3–5.

3. Türk Eximbank Export Credit and Insurance

Türk Eximbank (Turkey's Export Credit Bank) offers three critical instruments for medical device exporters:

• Short-Term Export Credit Insurance: Covers buyer default and country transfer risk on open account sales up to 360 days. Premium ~0.2–0.8% of invoice value depending on country risk rating. Enables Turkish exporters to offer open account terms safely to established distributors.
• Buyer Credit (İhracat Alıcı Kredisi): Türk Eximbank lends directly to foreign buyers to purchase Turkish products. The foreign distributor repays Türk Eximbank in foreign currency over 1–5 years. This enables Turkish exporters to receive immediate full payment while offering the buyer financing.
• Specific Export Credit Insurance: Single-buyer policies for large capital equipment transactions (hospital furniture tenders, imaging equipment) covering the full contract value against buyer and country risk.

How to access: Apply through your Turkish commercial bank (Ziraat, İş, Garanti, Yapı Kredi are all Türk Eximbank intermediaries) or directly at eximbank.gov.tr. Most applications can be processed within 2 weeks.

4. Advance Payment — The Simplest but Rarest Option

Advance payment means the distributor pays before shipment. This eliminates all credit risk for the Turkish exporter but is only acceptable to sophisticated distributors with cash flow strength and very high trust in the manufacturer. Typically used in the early stages of a relationship when the distributor is eager to begin, or when goods are custom-manufactured to specification.

Partial advance payment (30–50% upfront, balance before shipment) is a practical compromise for new relationships, particularly in Africa and Southeast Asia where L/C opening costs are relatively high for small orders.

5. Factoring and Invoice Discounting

Export factoring allows Turkish manufacturers to sell their receivables to a factoring company (factor) immediately upon invoice, receiving 75–85% of the invoice value within 24–48 hours. The factor collects the full amount from the buyer and remits the balance (minus factoring fee of 1.5–4%).

International factoring is facilitated through the Factors Chain International (FCI) network. Turkish factoring companies (İş Faktoring, Garanti Faktoring) have international correspondents that can cover most of Turkey's key medical device export markets. FCI two-factor system provides full recourse protection for the Turkish manufacturer even if the buyer defaults.

Best for: Manufacturers with established distributor relationships who need to improve cash flow without waiting 60–90 days for payment.

Choosing the Right Instrument: A Decision Framework

The optimal payment structure evolves with the distributor relationship. Start with maximum security (L/C or advance payment) and progressively move to more flexible terms as track record develops.

Currency Risk Management

Turkish medical device exporters face currency risk on two sides: the TRY/USD or TRY/EUR exchange rate affects TRY-denominated costs, while distributor payments in exotic currencies (ETB, PKR, COP, MAD) add conversion complexity.

Best practice: always invoice in USD or EUR — never in the buyer's local currency unless the buyer's country restricts foreign currency invoicing. Use Türk Eximbank's Turkish Lira export credit facilities (to manage TRY cost base) combined with USD-denominated export pricing. Forward contracts through your commercial bank can lock in EUR/USD rates for 30–180 days, protecting margin on confirmed orders.